Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer
Author:
Affiliation:
1. Institute of Oncology, The Chaim Sheba Medical Center; Tel Hashomer Israel
2. Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center; Jerusalem Israel
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference14 articles.
1. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years;Malone;Cancer Res,2006
2. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations;Rennert;N Engl J Med,2007
3. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA);Mavaddat;Cancer Epidemiol Biomarkers Prev,2012
4. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study;Goodwin;J Clin Oncol,2012
5. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features;Tung;Breast Cancer Res,2010
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. ER-positive and BRCA2-mutated breast cancer: a literature review;European Journal of Medical Research;2024-01-06
2. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients;npj Breast Cancer;2023-11-30
3. Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations;Discover Oncology;2023-06-23
4. Systemic treatment of breast cancer in young patients with a germline mutation in the BRCA1 and BRCA2 genes;Onkologie;2023-06-16
5. Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation;British Journal of Cancer;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3